New cell therapy targets multiple advanced cancers in early trial
NCT ID NCT05239143
First seen Nov 06, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This early-phase study tests an experimental cell therapy called P-MUC1C-ALLO1 in 180 adults with advanced solid tumors (e.g., breast, ovarian, lung, pancreatic cancers) that have not responded to standard treatments. The therapy uses donor immune cells engineered to attack cancer cells. The main goals are to find the safest dose and check for early signs of tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center of Kansas
Wichita, Kansas, 67214, United States
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
Sarah Cannon Research Institute at HealthONE
Denver, Colorado, 80218, United States
-
University of California, Irvine Medical Center
Irvine, California, 92868, United States
-
University of California, San Diego
San Diego, California, 92037, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Maryland Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.